Point of Care Infectious Disease Testing Market by Diseases (HIV POC, Clostridium Difficile POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB & Drug-resistant TB POC, HSV POC, and Other Infectious Disease POC), End-users (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global point of care infectious disease testing market size is projected to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the current developments in consumer-centric services, high demand for portable and rapid testing products, and rapid increase in the number of cases of infectious diseases.
A point-of-care (POC) test is a kind of screening process and medical examination is adopted at or near the location of patients. The test allows quick testing process and enhances convenience of patients by providing easy access to several medical facilities, which lead to the improvement in patient treatment. With the advancement of POC testing, it helps to eliminate the need for repeated hospital visits, allowing for prompt healthcare actions, and effective treatment methods for infectious diseases.
Increasing inclination towards home healthcare from patients suffering from infectious disease present a key factor driving the market growth of the market. Rising demand for home healthcare can be attributed to introduction of several governments’ initiatives and growing patient awareness that has resulted to reducing hospital stays and healthcare expenses related to it.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing communicable disease occurrence and prevalence rates along with an ageing population with lower immunity are expected to drive the market expansion.
- Introduction of mobile and self-testing technology has expanded access to testing and tracking services to rural locations where there is a lack of prompt medical attention. This is a major market driver.
- Other than existing companies, new industry players are designing a large number of novel and groundbreaking algorithms and solutions. These solutions are expected to help in the market expansion.
- Increasing demand for localized research and declining ability of central laboratories to satisfy the increasing demand for healthcare are key factors boosting the market revenue.
- Strict regulatory policies in the diagnostic devices approval and lack of experts handling testing procedures are anticipated to impede the market growth.
- Increasing partner diagnostics adoption, infectious disease virulence, and the need for improved and more frequent surveillance systems in near-patient settings are offering several opportunities for the market growth.
Scope of Point of Care Infectious Disease Testing Market Report
The report on the global point of care infectious disease testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Point of Care Infectious Disease Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Diseases (HIV POC, Clostridium Difficile POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB & Drug-resistant TB POC, HSV POC, and Other Infectious Disease POC) and End-users (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Alere, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioMérieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., and Ortho-Clinical Diagnostics. |
Point of Care Infectious Disease Testing Market Segment Insights
HIV POC test segment is projected to account a major market share
Based on the diseases, the point of care infectious disease testing market is divided into HIV POC, Clostridium difficile POC, HBV POC, pneumonia or streptococcus associated infections, respiratory syncytial virus (RSV) POC, HPV POC, influenza/flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV POC, and other infectious disease POC.
The HIV POC test segment is expected to account for a key share of the market during the forecast period owing to the advancement and delivery of responsive and reliable device for the treatment of AIDS/HIV. However, the influenza/flu POC segment is anticipated to expand at a rapid pace during the forecast period owing to increasing disease incidence rates.
Clinics segment is projected to represent a key market share
On the basis of end-users, the market is segregated into hospitals, clinics, home, assisted living healthcare facilities, laboratories, and others. The clinics segment is expected to hold a key share of the market in the coming years due to increased use of these instruments and platforms in clinics. On the other hand, the assisted living healthcare facilities segment is anticipated to expand at a rapid pace during the forecast period owing to increased use of this market as a result of the demand from the geriatric population base.
North America is anticipated to dominate the market
On the basis of regions, the global point of care infectious disease testing market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to the participation of major players, a well-established healthcare system, and technical advancements in this region. However, the market of Asia Pacific is expected to exhibit a rapid growth rate in the coming years due to increased R&D spending in patient-centered hospitals in Japan and China, the rapidly rising burden of chronic infectious diseases, and the presence of government programs that aimed at promoting early diagnosis.
Segments
The global point of care infectious disease testing market has been segmented on the basis of
Diseases
- HIV POC
- Clostridium Difficile POC
- HBV POC
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB & Drug-resistant TB POC
- HSV (Herpes Simplex Virus) POC
- Other Infectious Disease POC
End-users
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Alere
- Thermo Fisher Scientific Inc
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- BD & Company
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Inc.
- Bio-Rad Labs Inc.
- bioMérieux SA
- Sight Diagnostics Ltd.
- Gene POC
- Trivitron Healthcare
- OJ-Bio Ltd.
- Ortho-Clinical Diagnostics
Competitive Landscape
Key players competing in the global point of care infectious disease testing market are Alere, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioMérieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., and Ortho-Clinical Diagnostics.
Some of these players are establishing strategic alliances with other existing and emerging organizations. The partnerships aim to increase their market share by developing a broad product range that help in accurate diagnosis process.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Point of Care Infectious Disease Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Point of Care Infectious Disease Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Point of Care Infectious Disease Testing Market - Supply Chain
4.5. Global Point of Care Infectious Disease Testing Market Forecast
4.5.1. Point of Care Infectious Disease Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Point of Care Infectious Disease Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Point of Care Infectious Disease Testing Market Absolute $ Opportunity
5. Global Point of Care Infectious Disease Testing Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
5.3.1. Hospitals
5.3.2. Clinics
5.3.3. Home
5.3.4. Assisted Living Healthcare Facilities
5.3.5. Laboratories
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Point of Care Infectious Disease Testing Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Point of Care Infectious Disease Testing Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
7. North America Point of Care Infectious Disease Testing Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Home
7.4.4. Assisted Living Healthcare Facilities
7.4.5. Laboratories
7.4.6. Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
8. Latin America Point of Care Infectious Disease Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Home
8.4.4. Assisted Living Healthcare Facilities
8.4.5. Laboratories
8.4.6. Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
9. Europe Point of Care Infectious Disease Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home
9.4.4. Assisted Living Healthcare Facilities
9.4.5. Laboratories
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
10. Asia Pacific Point of Care Infectious Disease Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home
10.4.4. Assisted Living Healthcare Facilities
10.4.5. Laboratories
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
11. Middle East & Africa Point of Care Infectious Disease Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home
11.4.4. Assisted Living Healthcare Facilities
11.4.5. Laboratories
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Point of Care Infectious Disease Testing Market: Market Share Analysis
12.2. Point of Care Infectious Disease Testing Distributors and Customers
12.3. Point of Care Infectious Disease Testing Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Alere
12.4.2. Thermo Fisher Scientific Inc
12.4.3. F. Hoffmann-La Roche Ltd
12.4.4. Siemens Healthineers
12.4.5. BD & Company
12.4.6. Chembio Diagnostics Inc.
12.4.7. Trinity Biotech
2. Assumptions and Acronyms Used
3. Research Methodology
4. Point of Care Infectious Disease Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Point of Care Infectious Disease Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Point of Care Infectious Disease Testing Market - Supply Chain
4.5. Global Point of Care Infectious Disease Testing Market Forecast
4.5.1. Point of Care Infectious Disease Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Point of Care Infectious Disease Testing Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Point of Care Infectious Disease Testing Market Absolute $ Opportunity
5. Global Point of Care Infectious Disease Testing Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
5.3.1. Hospitals
5.3.2. Clinics
5.3.3. Home
5.3.4. Assisted Living Healthcare Facilities
5.3.5. Laboratories
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Point of Care Infectious Disease Testing Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Point of Care Infectious Disease Testing Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
7. North America Point of Care Infectious Disease Testing Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Home
7.4.4. Assisted Living Healthcare Facilities
7.4.5. Laboratories
7.4.6. Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
8. Latin America Point of Care Infectious Disease Testing Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Home
8.4.4. Assisted Living Healthcare Facilities
8.4.5. Laboratories
8.4.6. Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
9. Europe Point of Care Infectious Disease Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home
9.4.4. Assisted Living Healthcare Facilities
9.4.5. Laboratories
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
10. Asia Pacific Point of Care Infectious Disease Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home
10.4.4. Assisted Living Healthcare Facilities
10.4.5. Laboratories
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
11. Middle East & Africa Point of Care Infectious Disease Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Point of Care Infectious Disease Testing Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Point of Care Infectious Disease Testing Market Size and Volume Forecast by End Users
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home
11.4.4. Assisted Living Healthcare Facilities
11.4.5. Laboratories
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Point of Care Infectious Disease Testing Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Point of Care Infectious Disease Testing Market: Market Share Analysis
12.2. Point of Care Infectious Disease Testing Distributors and Customers
12.3. Point of Care Infectious Disease Testing Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Alere
12.4.2. Thermo Fisher Scientific Inc
12.4.3. F. Hoffmann-La Roche Ltd
12.4.4. Siemens Healthineers
12.4.5. BD & Company
12.4.6. Chembio Diagnostics Inc.
12.4.7. Trinity Biotech
The global point of care infectious disease testing market has been segmented on the basis of
Diseases
- HIV POC
- Clostridium Difficile POC
- HBV POC
- Pneumonia or Streptococcus Associated Infections
- Respiratory Syncytial Virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- HCV POC
- MRSA POC
- TB & Drug-resistant TB POC
- HSV (Herpes Simplex Virus) POC
- Other Infectious Disease POC
End-users
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Alere
- Thermo Fisher Scientific Inc
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- BD & Company
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Inc.
- Bio-Rad Labs Inc.
- bioMérieux SA
- Sight Diagnostics Ltd.
- Gene POC
- Trivitron Healthcare
- OJ-Bio Ltd.
- Ortho-Clinical Diagnostics
Key players competing in the global point of care infectious disease testing market are Alere, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., bioMérieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., and Ortho-Clinical Diagnostics.
Some of these players are establishing strategic alliances with other existing and emerging organizations. The partnerships aim to increase their market share by developing a broad product range that help in accurate diagnosis process.
Our Clients
Related Reports
Some other reports from this category!
